Navigation Links
ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
Date:1/29/2009

which has pioneered the study of using bone marrow stem cells as therapy. Patients with CLI are often faced with the prospect of amputation and suffer high rates of morbidity and mortality. We are optimistic that our MXP technology will ultimately enable clinicians to achieve more successful outcomes for these patients," said Matthew Plavan, Chief Executive Officer of ThermoGenesis.

The MXP System is derived from ThermoGenesis' AXP(TM) AutoXpress technology platform, which is routinely used in cord blood banking processing by both private and public cord blood banks throughout the world. The MXP features a microprocessor controlled device and a dedicated single-use disposable set for isolating stem cells present in bone marrow aspirates. The offering represents first to market technology allowing clinicians to automate the volume reduction steps and cryopreservation of processed bone marrow aspirates. The output of the MXP is compatible for stem cell cryopreservation using the ThermoGenesis BioArchive(R) System.

A second initiative involves the use of the MXP to perform clinical research on bone marrow stem cell separation in point-of-care orthopedic procedures. In September 2008, ThermoGenesis announced the signing of a distribution agreement with Austin, Texas-based Celling Technologies that covers distribution rights for the field of use in orthopedics intraoperative or point-of-care applications.

"This partnership with Celling Technologies, a true innovator in the orthopedics industry, portends a significant opportunity for ThermoGenesis. We are in the process of completing our training and market introduction programs with them and look forward to a mutually beneficial relationship," Plavan noted.

"With the recent change in administrations in Washington, it is likely that there will be increased funding and support for stem cell research. We are hopeful that a more favorable climate can lead
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
2. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
3. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
4. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
5. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
6. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
7. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
8. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
9. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
10. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
11. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Nuclear medicine market is estimated to ... Nuclear are drugs that contain radionuclide-emitting ionization radiation, ... and treat diseases. Increasing incidences of ... and ready availability of radiopharmaceuticals are the major ... awareness and use of SPECT and PET also ...
(Date:9/23/2014)...  SI-BONE, Inc., a medical device company that pioneered ... a minimally invasive surgical (MIS) device indicated for fusion ... U.S. Patent and Trademark Office has awarded the company ... fixation and fusion of bone.  This newly issued patent ... may be placed from one bone across a joint ...
(Date:9/23/2014)... , Sept. 23, 2014   LabStyle Innovations ... Diabetes Management Solution, today announced that it has ... of shares of preferred stock and warrants.  No ... estimated offering expenses, LabStyle expects to secure net ... LabStyle intends to use the ...
Breaking Medicine Technology:Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 2LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 3LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 4LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing 5
... Use of,a low profile PressureWire yields a ... to catheter-derived pressure gradient,(CPG) measurements, according to a ... Vol. 20, Issue 1: 63-65)., The authors ... a,catheter and PressureWire correlated with anatomic stenosis, PressureWire,gradient ...
... 27 Puroast(R) Low Acid Coffee,has conducted both ... its great tasting, gourmet coffee provides symptom relief ... brew. Puroast(R) achieves,this without extractions, substitutes or additives; ... full-bodied taste., Prior chemistry research at University ...
Cached Medicine Technology:Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report 2Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report 3Low Acid Coffee Backed By Scientific Research 2
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... "The primary purpose of the CALL LIGHT CADDY is patient ... "Call lights are often found on the floor, lost in ... out of the patient's reach. In order to make sure ... it, I created this caddy." , She developed the CALL ... easy reach. The accessory ensures that the call device can ...
(Date:9/23/2014)... A new analysis of published studies found that ... cancer versus benign disease in regions where infections ... of lung lesions suspicious for cancer could lead ... additional potential complications and mortality. , Histoplasmosis ... that are often concentrated in bird droppings and ...
(Date:9/23/2014)... NIH TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF ... WHAT: , The National Institutes of Health is ... available scientific evidence on the long-term effectiveness and potential ... be among the nation,s top experts in the field ... as well as key NIH scientists who focus on ...
(Date:9/23/2014)... The University of California, Davis, and Academia Sinica, ... China (Taiwan), have entered into a collaborative agreement ... program that couples cutting-edge research with opportunities to ... new companies. , The agreement was signed Sept.12 ... research at UC Davis and President Chi-Huey Wong ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2
... rehabilitation professionals expect 20-plus percent employment increases through 2016. ... ... September 8, 2008 -- People reach significant milestones through ... the http://www.nraf-rehabnet.org/ [National Rehabilitation Awareness Foundation], which ...
... Common painkillers like aspirin and ibuprofen appear to lower a ... to help gauge whether a man is at risk of ... appears online Sept. 8 in the journal Cancer , ... to prevent prostate cancer just yet. , "We showed ...
... Pa., Sept. 5 Lieutenant Governor,Catherine Baker Knoll today ... Blood Donor Day., The Commonwealth of Pennsylvania and ... to give blood in commemoration of those who lost ... supplies. One blood,donation can save up to three lives., ...
... John McCain to commit to develop a National AIDS,Strategy ... Sep. 5 The,Republican National Convention concluded last night ... United States and only passing reference to,the epidemic overseas. ... Gov. Sarah Palin mentioned AIDS in their remarks,to Convention ...
... 5 On Saturday, September 6, PARI,Respiratory Equipment will ... part of their "Breathe Easier" series. PARI is highlighted ... as COPD,sufferers, with effective nebulizers and compressors that deliver ... to improve the lives of those affected by respiratory,diseases ...
... disease resistance to anti-hormonal therapy , , FRIDAY, Sept. ... help "re-sensitize" certain breast cancer tumors to anti-hormonal ... , Women with estrogen-receptor or progesterone-receptor positive (ER ... anti-hormonal medicines, such as aromatase inhibitors, to keep ...
Cached Medicine News:Health News:U.S. Demand for Rehabilitation Professionals Grows 2Health News:U.S. Demand for Rehabilitation Professionals Grows 3Health News:Common painkillers lower levels of prostate cancer biomarker 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: